181 related articles for article (PubMed ID: 9454823)
1. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
Nicole P; Du K; Couvineau A; Laburthe M
J Pharmacol Exp Ther; 1998 Feb; 284(2):744-50. PubMed ID: 9454823
[TBL] [Abstract][Full Text] [Related]
2. [Directed mutagenesis of human recombinant receptors of vasoactive intestinal peptide of VIP1 and VIP2 type. Difference in structure-activity relationship].
Nicole P; Du K; Couvineau A; Laburthe M
Gastroenterol Clin Biol; 1997; 21(5):365-9. PubMed ID: 9208011
[TBL] [Abstract][Full Text] [Related]
3. Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.
Du K; Nicole P; Couvineau A; Laburthe M
Biochem Biophys Res Commun; 1997 Jan; 230(2):289-92. PubMed ID: 9016768
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
Biochemistry; 1996 Feb; 35(6):1745-52. PubMed ID: 8639654
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
Nicole P; Maoret JJ; Couvineau A; Momany FA; Laburthe M
Biochem Biophys Res Commun; 2000 Sep; 276(2):654-9. PubMed ID: 11027527
[TBL] [Abstract][Full Text] [Related]
6. The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343.
Gaudin P; Couvineau A; Rouyer-Fessard C; Maoret JJ; Laburthe M
Biochem Biophys Res Commun; 1999 Jan; 254(1):15-20. PubMed ID: 9920725
[TBL] [Abstract][Full Text] [Related]
7. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Gourlet P; Vandermeers A; Van Rampelbergh J; De Neef P; Cnudde J; Waelbroeck M; Robberecht P
Ann N Y Acad Sci; 1998 Dec; 865():247-52. PubMed ID: 9928018
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors.
Gaudin P; Maoret JJ; Couvineau A; Rouyer-Fessard C; Laburthe M
J Biol Chem; 1998 Feb; 273(9):4990-6. PubMed ID: 9478946
[TBL] [Abstract][Full Text] [Related]
9. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.
Gourlet P; Vertongen P; Vandermeers A; Vandermeers-Piret MC; Rathe J; De Neef P; Waelbroeck M; Robberecht P
Peptides; 1997; 18(3):403-8. PubMed ID: 9145428
[TBL] [Abstract][Full Text] [Related]
10. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
[TBL] [Abstract][Full Text] [Related]
11. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
Van Rampelbergh J; Juarranz MG; Perret J; Bondue A; Solano RM; Delporte C; De Neef P; Robberecht P; Waelbroeck M
Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
[TBL] [Abstract][Full Text] [Related]
13. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
Marie JC; Rouyer-Fessard C; Couvineau A; Nicole P; Devaud H; El Benna J; Laburthe M
Mol Pharmacol; 2003 Dec; 64(6):1565-74. PubMed ID: 14645688
[TBL] [Abstract][Full Text] [Related]
14. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
Jiang X; Wang HY; Yu J; Ganea D
Ann N Y Acad Sci; 1998 Dec; 865():397-407. PubMed ID: 9928038
[TBL] [Abstract][Full Text] [Related]
15. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
16. Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor.
Couvineau A; Rouyer-Fessard C; Laburthe M
Regul Pept; 2004 Dec; 123(1-3):181-5. PubMed ID: 15518910
[TBL] [Abstract][Full Text] [Related]
17. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions.
Usdin TB; Bonner TI; Mezey E
Endocrinology; 1994 Dec; 135(6):2662-80. PubMed ID: 7988457
[TBL] [Abstract][Full Text] [Related]
18. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
Langer I; Langlet C; Robberecht P
J Mol Endocrinol; 2005 Apr; 34(2):405-14. PubMed ID: 15821106
[TBL] [Abstract][Full Text] [Related]
19. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
20. Role of VIP1/PACAP receptors in postoperative ileus in rats.
De Winter BY; Robberecht P; Boeckxstaens GE; De Man JG; Moreels TG; Herman AG; Pelckmans PA
Br J Pharmacol; 1998 Jul; 124(6):1181-6. PubMed ID: 9720789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]